Top Story

Abaloparatide lowers fracture risk in postmenopausal osteoporosis

March 6, 2015

SAN DIEGO — A synthetic form of human parathyroid hormone-related protein, abaloparatide, significantly reduced the rate of new fractures in women with postmenopausal osteoporosis, according to study findings presented here.

In the phase 3 ACTIVE trial, new spinal fractures were reduced by 86%, and statistically significant reductions were found at other parts of the body.  

Ralph A. DeFronzo Meeting News Coverage

Liraglutide improves weight, HbA1c in overweight/obese adults with type 2 diabetes

March 5, 2015
SAN DIEGO — More patients with overweight and obesity achieved clinically meaningful weight loss with liraglutide 3 mg and 1.8 mg compared with placebo, according…
Peter Clayton Meeting News Coverage

Summer daylight exposure linked to growth in GH-deficient children

March 5, 2015
SAN DIEGO — Genes modulating growth and summer daylight exposure are subject to a complex gene–environment interaction in response to recombinant human…
Meeting News Coverage

Subclinical thyroid disease increased mortality risk in older adults

March 5, 2015
SAN DIEGO — Risk for mortality in older adults increased with diagnoses of subclinical hypothyroidism or subclinical hyperthyroidism, according to study findings…
Meeting News Coverage

Estimated cost burden of EDC exposure 'staggering' in EU, translates to US

March 5, 2015
SAN DIEGO — Exposure to endocrine-disrupting chemicals could cost the European Union as much as €157 billion, or $209 billion, per year in health care…
More News Headlines »
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
Hatipoglu th

Autologous islet cell transplantation effective for chronic pancreatitis

December 3, 2014
In this video exclusive, Betul Hatipoglu, MD, clinical associate professor of medicine of the Endocrinology &…
More »
Assessing Cornerstones for Successful Weight Loss

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United…
More »
Current Issues
View the Current Issues